One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.

Context.--Quantification and detection of the t(9;22) (BCR-ABL1) translocation in chronic myelogenous leukemia and B-lymphoblastic leukemia are important for directing treatment protocols and monitoring disease relapse. However, quantification using traditional reverse transcriptase quantitative pol...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Pathology & Laboratory Medicine Vol. 146; no. 1; pp. 92 - 101
Autores principales: Martinez, Ryan J., Qing Kang, Nennig, Davis, Bailey, Nathanael G., Brown, Noah A., Betz, Bryan L., Tewari, Muneesh, Thyagarajan, Bharat, Bachanova, Veronika, Mroz, Pawel
Formato: research tables/charts Journal Article
Publicado: College of American Pathologists Jan2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154443836&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 154443836
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00039985
        1FS
      jtl: Archives of Pathology & Laboratory Medicine
      issn: 00039985
      maglogo: N
    pubinfo:
      dt: Jan2022
      vid: 146
      iid: 1
      pid: 2550
      pub: College of American Pathologists
      place: Northfield, Illinois
    artinfo:
      ui:
        154443836
        154443836
        154443836
        10.5858/arpa.2020-0454-oa
        154443836
      ppf: 92
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.
      aug:
        au:
          Martinez, Ryan J.
          Qing Kang
          Nennig, Davis
          Bailey, Nathanael G.
          Brown, Noah A.
          Betz, Bryan L.
          Tewari, Muneesh
          Thyagarajan, Bharat
          Bachanova, Veronika
          Mroz, Pawel
        affil: Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis
      sug:
        subj:
          Polymerase Chain Reaction Methods
          Proteins
          B Lymphocytes
          Leukemia, Lymphocytic
          Human
          Reverse Transcriptase Polymerase Chain Reaction
          Sensitivity and Specificity
          Descriptive Statistics
      ab: Context.--Quantification and detection of the t(9;22) (BCR-ABL1) translocation in chronic myelogenous leukemia and B-lymphoblastic leukemia are important for directing treatment protocols and monitoring disease relapse. However, quantification using traditional reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) is dependent on a calibration curve and is prone to laboratory-to-laboratory variation. Droplet digital poly-merase chain reaction (ddPCR) is a novel method that allows for highly sensitive absolute quantification of transcript copy number. As such, ddPCR is a good candidate for disease monitoring, an assay requiring reproducible measurements with high specificity and sensitivity. Objective.--To compare results of ddPCR and RT-qPCR BCR-ABL1 fusion transcript measurements of patient samples and determine if either method is superior. Design.--We optimized and standardized a 1-step multiplexed ddPCR assay to detect BCR-ABL1 p190 and ABL1 e10 transcripts. The ddPCR optimization included varying cycle number and primer concentration with standardization of droplet generation and droplet number and analyses to improve data sensitivity. Following optimization, ddPCR measurements were performed on clinical samples and compared with traditional RT-qPCR results. Results.--Droplet digital polymerase chain reaction was able to detect the BCR-ABL1 p190 transcript to 0.001% (1:10-5) with a calculated limit of detection and limit of quantitation of 4.1 and 5.3 transcripts, respectively. When tested on patient samples, ddPCR was able to identify 20% more positives than a laboratory-developed 2-step RT-qPCR assay. Conclusions.--Droplet digital polymerase chain reaction demonstrated increased detection of BCR-ABL1 compared with RT-qPCR. Improved detection of BCR-ABL1 p190 and the potential for improved standardization across multiple laboratories makes ddPCR a suitable method for disease monitoring in patients with acute B-lymphoblastic leukemia.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N